• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

K-ras基因的突变分析支持肺双相性多形性癌的单克隆起源。

K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.

作者信息

Pelosi Giuseppe, Scarpa Aldo, Manzotti Michela, Veronesi Giulia, Spaggiari Lorenzo, Fraggetta Filippo, Nappi Oscar, Benini Elvira, Pasini Felice, Antonello Davide, Iannucci Antonio, Maisonneuve Patrick, Viale Giuseppe

机构信息

Department of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy.

出版信息

Mod Pathol. 2004 May;17(5):538-46. doi: 10.1038/modpathol.3800058.

DOI:10.1038/modpathol.3800058
PMID:14990969
Abstract

We investigated 27 pleomorphic carcinomas of the lung for exon 1 K-ras gene mutations using polymerase chain reaction-single-strand conformation polymophism analysis and direct sequencing. All pleomorphic carcinomas were biphasic, that is, composed of an adeno-, squamous- or large-cell-carcinomatous component associated with a spindle- and/or giant-cell component. Of 27 cases, six (22%) showed K-ras codon 12 mutations, which is a figure higher than that previously reported on in pure sarcoma-like pleomorphic carcinomas. Five tumors displayed the same mutation in both the epithelial and the sarcomatoid components, whereas in one tumor the mutation was restricted to the epithelial component. All mutations occurred in smokers, and were transversions, including GGT (glycine) to TGT (cysteine) change in two cases, to GCT (alanine) in two and to GTT (valine) in two. No significant relationships were found between the occurrence and type of mutations and patients' survival or any other clinicopathological variable, suggesting that K-ras mutations are early events in the development of these tumors. Our results indicate that most, though not all, biphasic pleomorphic carcinomas of the lung are monoclonal in origin, and that cigarette smoking may have a causative role in the development of K-ras alterations in these tumors, as all mutations are transversions.

摘要

我们采用聚合酶链反应-单链构象多态性分析及直接测序法,对27例肺多形性癌的第1外显子K-ras基因突变情况进行了研究。所有多形性癌均为双相性,即由腺、鳞或大细胞癌成分与梭形和/或巨细胞成分组成。27例病例中,6例(22%)出现K-ras密码子12突变,这一数字高于先前报道的纯肉瘤样多形性癌。5例肿瘤的上皮成分和肉瘤样成分均显示相同突变,而1例肿瘤的突变仅局限于上皮成分。所有突变均发生在吸烟者中,且均为颠换,包括2例由GGT(甘氨酸)突变为TGT(半胱氨酸),2例突变为GCT(丙氨酸),2例突变为GTT(缬氨酸)。未发现突变的发生及类型与患者生存或任何其他临床病理变量之间存在显著相关性,提示K-ras突变是这些肿瘤发生发展过程中的早期事件。我们的结果表明,大多数(尽管不是全部)肺双相性多形性癌起源于单克隆,且吸烟可能在这些肿瘤的K-ras改变发生过程中起致病作用,因为所有突变均为颠换。

相似文献

1
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.K-ras基因的突变分析支持肺双相性多形性癌的单克隆起源。
Mod Pathol. 2004 May;17(5):538-46. doi: 10.1038/modpathol.3800058.
2
Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.煤矿工人肺癌中p53和K-ras的分子分析。
Int J Mol Med. 2001 Oct;8(4):453-9. doi: 10.3892/ijmm.8.4.453.
3
Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.p53和K-ras基因的突变作为非小细胞肺癌的预后因素
Int J Oncol. 1998 Mar;12(3):553-63. doi: 10.3892/ijo.12.3.553.
4
Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.非小细胞肺癌(NSCLC)肿瘤及手术切缘中p53和k-ras密码子12突变的低频率
Tumori. 2007 Sep-Oct;93(5):473-7. doi: 10.1177/030089160709300511.
5
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.肺鳞状细胞癌中K-ras癌基因的突变及H-ras突变的缺失
Clin Cancer Res. 1995 Mar;1(3):359-65.
6
A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.一种使用福尔马林固定石蜡包埋组织对非小细胞肺癌中K-ras和p53基因进行突变分析的通用方法。
Diagn Mol Pathol. 1995 Dec;4(4):266-73. doi: 10.1097/00019606-199512000-00007.
7
Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.肺癌中K-ras基因突变分析:与性别、组织学亚型及临床结局的相关性
J Cancer Res Clin Oncol. 1998;124(9):517-22. doi: 10.1007/s004320050208.
8
K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer.K-ras 点突变发生在肺癌致癌作用的早期阶段。
Br J Cancer. 1998 Mar;77(5):720-3. doi: 10.1038/bjc.1998.118.
9
Distribution of p53 and K-ras mutations in human lung cancer tissues.人肺癌组织中p53和K-ras突变的分布
Carcinogenesis. 1997 Mar;18(3):473-8. doi: 10.1093/carcin/18.3.473.
10
K-ras gene mutations in non-small cell lung cancer in Japanese.日本非小细胞肺癌中的K-ras基因突变
Oncol Rep. 2001 Jul-Aug;8(4):889-92. doi: 10.3892/or.8.4.889.

引用本文的文献

1
Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population.组织学亚型对肺肉瘤样癌围手术期化疗疗效的影响:一项基于监测、流行病学与结果(SEER)数据库人群的回顾性研究
Transl Lung Cancer Res. 2024 Apr 29;13(4):749-762. doi: 10.21037/tlcr-24-41. Epub 2024 Apr 17.
2
Demographics and Clinicopathologic Profile of Pulmonary Sarcomatoid Carcinoma with Survival Analysis and Genomic Landscape.肺肉瘤样癌的人口统计学与临床病理特征及生存分析和基因组图谱
Cancers (Basel). 2023 Apr 26;15(9):2469. doi: 10.3390/cancers15092469.
3
Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre.
肺肉瘤样癌的特征与临床结局:来自塔塔纪念中心的经验
Ecancermedicalscience. 2022 Aug 8;16:1438. doi: 10.3332/ecancer.2022.1438. eCollection 2022.
4
Pulmonary pleomorphic carcinoma presenting as undifferentiated non-small cell carcinoma with giant cells: A case report and review of literature.表现为伴有巨细胞的未分化非小细胞癌的肺多形性癌:一例报告并文献复习
Respir Med Case Rep. 2020 Sep 14;31:101225. doi: 10.1016/j.rmcr.2020.101225. eCollection 2020.
5
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.综合分子特征分析揭示了肺肉瘤样癌的潜在治疗策略。
Nat Commun. 2020 Sep 28;11(1):4878. doi: 10.1038/s41467-020-18702-3.
6
Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma.肺肉瘤样癌的肿瘤分类方法
Lung Cancer (Auckl). 2019 Dec 5;10:131-149. doi: 10.2147/LCTT.S186779. eCollection 2019.
7
New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles.基于基因组和系统发育图谱的肺肉瘤样癌新治疗靶点
Oncotarget. 2018 Jan 31;9(12):10635-10649. doi: 10.18632/oncotarget.24365. eCollection 2018 Feb 13.
8
EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features.肺多形性癌中EGFR和KRAS突变及其与临床病理特征的相关性。
Contemp Oncol (Pozn). 2015;19(1):22-7. doi: 10.5114/wo.2014.43491. Epub 2015 Mar 26.
9
Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy.肺肉瘤样癌:化疗耐药模型
N Am J Med Sci. 2014 Jul;6(7):342-5. doi: 10.4103/1947-2714.136920.
10
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.肺腺癌中可操作突变与组织学亚型结构域的映射:对精准医学的启示。
Oncotarget. 2014 Apr 30;5(8):2107-15. doi: 10.18632/oncotarget.1840.